Centocor Gains Access to GeneNews' Biomarkers | GenomeWeb
NEW YORK (GenomeWeb News) – GeneNews today said that it has signed an agreement with Centcor granting the drug firm selected access to research from its osteoarthritis genomic biomarker program.
Heiner Dreissman, interim CEO and lead director of GeneNews, said in a statement that the firm’s Sentinel Principle, its biomarker-discovery platform, was validated around osteoarthritis. He added that the collaboration is “a source of non-dilutive funding that will contribute to our commercialization efforts.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.